G
Galmed Pharmaceuticals Ltd
GLMD
0.31000
USD
-0.0035
(-1.12%)
مفتوح الان
حجم التداول
1,584
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
6,721,184
الأخبار
العنوان: Galmed Pharmaceuticals Ltd
القطاع: Healthcare
الصناعة: Biotechnology
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIaclinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.